Cas:314771-76-1 (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine manufacturer & supplier

We serve Chemical Name:(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine CAS:314771-76-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine

Chemical Name:(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
CAS.NO:314771-76-1
Synonyms:4,6-Quinazolinediamine, N-(3-chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-;N-(3-Chloro-4-fluorophenyl)-7-[(3S)-tetrahydro-3-furanyloxy]-4,6-quinazolinediamine;QC-4224;(S)-N4-(3-Chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine;T66 BN DNJ EMR CG DF& HZ IO- CT%OTJ &&S Form;N4-(3-Chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4,6-quinazolinediamine;(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-di;N4-(3-Chloro-4-fluorophenyl)-7-[(3S)-tetrahydro-3-furanyloxy]-4,6-quinazolinediamine;Afatinib Impurity 2
Molecular Formula:C18H16ClFN4O2
Molecular Weight:374.797
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:559.0±50.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.705
PSA:82.29000
Exact Mass:374.094574
LogP:2.95

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4,6-Quinazolinediamine, N-(3-chloro-4-fluorophenyl)-7-[[(3S)-tetrahydro-3-furanyl]oxy]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Afatinib Impurity 2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-di Use and application,QC-4224 technical grade,usp/ep/jp grade.


Related News: After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. methyl 6-{[(1’R,3’S,4’S,5’R,6’S)-3′-{tert-butyl(dimethyl)silyloxy}-6′-({tert-butyl(dimethyl)silyloxy}methyl)-4′,5′-O-(1-methylethylidene)-3′,4′,5′-trihydroxycyclohexyl]amino}-2,3,4-tri-O-benzyl-6-deoxy-α-D-glucopyranoside manufacturers Enzymes play a pivotal role in the catalysis of many different bio-transformation reactions in nature, typically exerting their effects under mild, neutral conditions. phosphonous acid suppliers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. nitroxyl vendor & factory.